4.5 Review

Lung cancer and β-glucans: review of potential therapeutic applications

Journal

INVESTIGATIONAL NEW DRUGS
Volume 35, Issue 4, Pages 509-517

Publisher

SPRINGER
DOI: 10.1007/s10637-017-0449-9

Keywords

Lung cancer; beta-glucans; Immunomodulatory activity; Drug resistance

Ask authors/readers for more resources

The potential of natural substances with immunotherapeutic properties has long been studied. beta-glucans, a cell wall component of certain bacteria and fungi, potentiate the immune system against microbes and toxic substances. Moreover, beta-glucans are known to exhibit direct anticancer effects and can suppress cancer proliferation through immunomodulatory pathways. Mortality of lung cancer has been alarmingly increasingly worldwide; therefore, treatment of lung cancer is an urgent necessity. Numerous researchers are now dedicated to using beta-glucans as a therapy for lung cancer. In the present attempt, we have reviewed the studies addressing therapeutic effects of beta-glucans in primary and metastatic lung cancer published in the time period of 1991-2016.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available